Table 2.
Summary of lymphocyte subset staining
| Patient outcome | No. of patients with graded CD3+ infiltrate* | No. of patients with graded CD20+ infiltrate* | No. of patients with % FoxP3+ amongst T cells* | |||
|---|---|---|---|---|---|---|
| Grade 0/1 | Grade 2/3 | Grade 0/1 | Grade 2/3 | <50 % | >50 % | |
| Censored | 7 | 5 | 10 | 2 | 1 | 9 |
| Death | 4 | 1 | 5 | 0 | 3 | 2 |
| Log-rank test (p value) | 0.8 | 0.54 | 0.69 | |||
| Recurrence | 4 | 2 | 6 | 0 | 3 | 3 |
| No recurrence | 7 | 4 | 9 | 2 | 1 | 8 |
| Log-rank test (p value) | 0.81 | 0.39 | 0.56 | |||
* Median survival times not calculated due to small number of events in each group